For women with BRCA mutation–positive (BRCAmut+) advanced ovarian cancer after 2 or more chemotherapies,
Face today with a therapy tailored to fit more women
Rubraca® (rucaparib) tablets are a treatment for women like you who have advanced ovarian cancer with a BRCA mutation and have received two or more chemotherapy medicines.
Rubraca is a prescription medicine used to treat people with advanced ovarian cancer who:
- Have certain "BRCA" gene mutations, either inherited (germline) or acquired (somatic)
- Have received previous treatment with 2 or more prior chemotherapy medicines for their cancer
Your doctor will perform a test to make sure Rubraca is right for you.
It is not known if Rubraca is safe and effective in children. Rubraca was approved based on response rate and how long patients’ responses lasted. There are ongoing studies to confirm the clinical benefit.
BRCA, Breast Cancer susceptibility gene.
Only use if your physician prescribed Rubraca to you. Do not give it to other people, even if they have the same symptoms you have. It may harm them. You can ask your doctor or pharmacist for more information about Rubraca. Keep Rubraca and all medicines out of the reach of children.